Cognitive function in breast cancer patients receiving adjuvant chemotherapy

Journal of Clinical Oncology

Volumn 18, Issue 14, 2000, Pages 2695-2701

  Brezden, Christine B ^a   Phillips, Kelly Anne ^a   Abdolell, Mohamed ^a   Bunston, Terry ^a   Tannock, Ian F ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 0033942083     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.14.2695     Document Type: Article

References (28)

1. National Cancer Institute of Canada: Canadian Cancer Statistics 1998. Toronto, Canada, National Cancer Institute of Canada, 1998
2. Landis SH, Murray T, Bolden S, et al: Cancer Statistics, 1998. CA Cancer J Clin 48:6-29, 1998
3. Bonadonna G, Brusamolino E, Valagussa P, et al: Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 94:405-410, 1976
4. Early Breast Cancer Trialists' Collaborative Group: Polychemotherapy for early breast cancer: An overview of the randomised trials - Early Breast Cancer Trialists' Collaborative Group. Lancet 352:930-942, 1998
5. Powles, TJ: Adjuvant therapy for early breast cancer: A time to define. J Natl Cancer Inst 89:1652-1654, 1997
6. Sitzia H, Huggins L: Side effects of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy for breast cancer. Cancer Pract 6:13-21, 1998
7. Greene D, Nail LM, Fieler VK, et al: A comparison of patient-reported side effects among three chemotherapy regimens for breast cancer. Cancer Pract 2:57-62, 1994
8. Dodwell DJ: Adjuvant cytotoxic chemotherapy for early breast cancer: Doubts and decisions. Lancet 351:1506-1507, 1998
9. Silberfarb PM, Philibert D, Levine PM: Psychosocial aspects of neoplastic disease: II. Affective and cognitive effects of chemotherapy in cancer patients. Am J Psychiatry 137:597-601, 1980
10. Oxman TE, Silberfarb PM: Serial cognitive testing in cancer patients receiving chemotherapy. Am J Psychiatry 137:1263-1265, 1980
11. Kaasa S, Olsnes T, Mastekaasa A: Neuropsychological evaluation of patients with inoperable non-small cell lung cancer treated with combination chemotherapy or radiotherapy. Acta Oncol 27:241-246, 1987
12. Devlen J, Maguire P, Phillips P, et al: Psychological problems associated with diagnosis and treatment of lymphomas: II. Prospective study. Br J Med 295:955-957, 1987
13. Parth P, Dunlap WP, Kennedy RS, et al: Motor and cognitive testing of bone marrow transplant patients after chemoradiotherapy. Percept Motor Skills 68:1227-1241, 1989
14. Andrykowski MA, Schmitt FA, Gregg ME, et al: Neuropsychological impairment in adult bone marrow transplant candidates. Cancer 70:2288-2297, 1992
15. Meyers CA, Abbruzzese JL: Cognitive functioning in cancer patients: Effect of previous treatment. Neurology 42:434-436, 1992
16. Meyers CA, Weitzner M, Byrne K, et al: Evaluation of the neurobehavioural functioning of patients before, during and after bone marrow transplantation. J Clin Oncol 12:820-826, 1994
17. Cull A, Gregor A, Hopwood P, et al: Neurological and cognitive impairment long-term survivors of small cell lung cancer. Eur J Cancer 30a: 1067-1074, 1994
18. Meyers CA, Byrne K, Komaki R: Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. Lung Cancer 12:231-235, 1995
19. Wieneke MH, Dienst ER: Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psychooncology 4:61-66, 1995
20. Ahles TA, Tope DM, Frustenberg C, et al: Psychological and neuropsychologic impact of autologous bone marrow transplantation. J Clin Oncol 14:1457-1462, 1996
21. Oosterhout AGM, Ganzevles PGJ, Wilmink JT, et al: Sequelae in long-term survivors of small cell lung cancer. Int J Radiat Oncol Biol Phys 5:1037-1044, 1996
22. van Dam FSAM, Schagen SB, Muller MJ, et al: Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210-218, 1998
23. Schagen SB, van Dam FSAM, Muller MJ, et al: Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640-650, 1999
24. Faust D, Fogel BS: The development and initial validation of a sensitive bedside cognitive screening test. J Nerv Ment Dis 177:25-31, 1989
25. McNair D, Lorr M, Droppleman L: EdITS Manual for the Profile of Mood States. San Diego, CA, Educational and Industrial Testing Service, 1992
26. SAS Institute Inc: SAS/STAT User's Guide, Release 6:03 Edition. Gary, NC. SAS Institute Inc, 1988
27. Becker RA, Chambers JM, Wilks AR: The New S Language. Pacific Grove, CA, Wadsworth, 1988
28. Altman DG: Practical Statistics for Medical Research (ed 1). London, United Kingdom, Chapman and Hall, 1991, p 33